Total: 11269, Nodes: 9446, Word count: 76796, All words count: 113145
View: Overview. Sorted by LCS.
Page 1:  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19

#	Word	Pubs	Percent	TLCS	TGCS
1	CHOLESTEROL	1346	14.2	8681	33962
2	DIETARY	1255	13.3	7394	29438
3	RATS	1163	12.3	6979	18850
4	EFFECT	1268	13.4	6147	23175
5	EFFECTS	1018	10.8	5876	21541
6	ACID	854	9.0	5460	14496
7	CONJUGATED	459	4.9	5323	9241
8	ATHEROSCLEROSIS	518	5.5	5261	15944
9	LINOLEIC	463	4.9	4682	8489
10	FIBER	460	4.9	4080	12571
11	RABBITS	356	3.8	3230	6893
12	PROTEIN	355	3.8	3214	7165
13	RAT	602	6.4	3112	13557
14	FED	363	3.8	2843	5911
15	EXPERIMENTAL	280	3.0	2635	5806
16	DIETS	308	3.3	2588	5729
17	INFLUENCE	347	3.7	2514	5901
18	METABOLISM	449	4.8	2075	11744
19	FAT	293	3.1	1927	6429
20	SERUM	433	4.6	1927	8719
21	LEVELS	288	3.0	1887	6187
22	CANCER	373	3.9	1885	10921
23	PLASMA	316	3.3	1882	7708
24	DIET	490	5.2	1737	8397
25	HUMAN	403	4.3	1734	11886
26	COLON	184	1.9	1671	6489
27	LIPIDS	432	4.6	1468	8207
28	CELLS	304	3.2	1444	10356
29	LIVER	338	3.6	1432	5673
30	ACIDS	357	3.8	1415	5671
#	Word	Pubs	Percent	TLCS	TGCS
31	COMPOSITION	258	2.7	1405	5010
32	SOYBEAN	128	1.4	1366	3101
33	CARCINOGENESIS	169	1.8	1322	4850
34	LIPID	405	4.3	1312	8112
35	TISSUE	159	1.7	1302	4949
36	RESTRICTION	186	2.0	1300	3303
37	LIPOPROTEINS	167	1.8	1294	7298
38	CASEIN	105	1.1	1278	2366
39	MICE	197	2.1	1259	4154
40	MAMMARY	111	1.2	1251	3624
41	FATTY	339	3.6	1247	5770
42	SOY	131	1.4	1234	4099
43	ABSORPTION	166	1.8	1194	4460
44	OIL	276	2.9	1157	2996
45	RISK	175	1.9	1083	9277
46	BRAN	114	1.2	1043	2568
47	COMPARISON	126	1.3	1036	2570
48	CALORIC	73	0.8	999	1701
49	CHOLESTEROL-FREE	40	0.4	994	1285
50	DIETARY-FAT	97	1.0	992	3391
51	LIPOPROTEIN	201	2.1	942	7460
52	BINDING	76	0.8	929	1674
53	AORTIC	123	1.3	919	3415
54	LIPID-METABOLISM	137	1.5	906	2252
55	DIETARY-PROTEIN	56	0.6	872	1366
56	RABBIT	174	1.8	872	6274
57	HEPATIC	176	1.9	871	4780
58	WHEAT	106	1.1	864	2283
59	CHROMATOGRAPHY	116	1.2	860	3675
60	INTAKE	141	1.5	860	3901
#	Word	Pubs	Percent	TLCS	TGCS
61	HYPERCHOLESTEROLEMIA	119	1.3	846	3705
62	SERUM-CHOLESTEROL	98	1.0	840	2538
63	GROWTH	178	1.9	804	5221
64	VEGETABLE	58	0.6	791	1377
65	BILE-ACIDS	85	0.9	789	2692
66	BILE-SALTS	23	0.2	782	961
67	BODY	71	0.8	766	1809
68	ISOMERS	81	0.9	760	1571
69	ACTIVITY	260	2.8	759	3908
70	DIFFERENT	160	1.7	752	2809
71	CONTENT	135	1.4	732	2606
72	VEHICLE	30	0.3	731	867
73	FECAL	112	1.2	730	2121
74	RELATION	76	0.8	728	3022
75	REVIEW	123	1.3	727	5527
76	INVITRO	126	1.3	726	2832
77	DIETARY-FIBERS	40	0.4	715	1149
78	HYPERCHOLESTEROLEMIC	109	1.2	715	2404
79	HYPOCHOLESTEROLEMIC	104	1.1	693	2134
80	CELL	137	1.5	692	3199
81	CHANGES	192	2.0	690	4033
82	STEROIDS	74	0.8	687	2187
83	PROTEINS	105	1.1	682	3813
84	LINOLEIC-ACID	17	0.2	677	1048
85	PLASMA-CHOLESTEROL	68	0.7	672	2161
86	INTESTINAL	157	1.7	661	3445
87	PECTIN	80	0.8	649	1380
88	TUMORIGENESIS	46	0.5	648	1813
89	TRANS	95	1.0	647	1522
90	SYNTHESIS	196	2.1	639	5001
#	Word	Pubs	Percent	TLCS	TGCS
91	CARBOHYDRATE	72	0.8	626	1783
92	PEANUT	58	0.6	619	932
93	FATTY-ACID	121	1.3	617	3258
94	FATTY-ACIDS	132	1.4	616	4002
95	MILK	144	1.5	616	2366
96	OXIDATION	83	0.9	605	1844
97	BILE-ACID	83	0.9	601	1890
98	BILE	175	1.9	586	3281
99	HAMSTERS	94	1.0	578	1085
100	EXCRETION	107	1.1	572	2384
101	PROMOTION	32	0.3	572	946
102	DIPLOID	38	0.4	566	1707
103	AGING	156	1.7	561	3618
104	CHOLESTEROL-METABOLISM	92	1.0	559	1822
105	DEVELOPMENT	155	1.6	558	3886
106	DISEASE	166	1.8	556	5792
107	BIOSYNTHESIS	112	1.2	551	4422
108	CLA	88	0.9	551	996
109	SERUM-LIPIDS	61	0.6	550	2238
110	CONCENTRATIONS	124	1.3	547	2371
111	ROLE	165	1.7	541	5057
112	ENERGY	96	1.0	536	1511
113	HUMANS	72	0.8	531	2284
114	REDUCES	65	0.7	529	1329
115	ESTER	113	1.2	528	2316
116	ANIMAL	90	1.0	517	2075
117	TRIGLYCERIDE	76	0.8	517	1936
118	HIGH	127	1.3	510	1843
119	MEN	88	0.9	501	2652
120	FEEDING	128	1.4	495	2135
#	Word	Pubs	Percent	TLCS	TGCS
121	CIS	45	0.5	491	966
122	PAPER	40	0.4	491	1083
123	STEROLS	107	1.1	485	2573
124	TURNOVER	50	0.5	482	1661
125	MONKEYS	67	0.7	480	1491
126	CONTAINING	95	1.0	475	1414
127	DETECTION	39	0.4	475	858
128	NORMAL	131	1.4	473	2990
129	PATIENTS	130	1.4	473	3209
130	INHIBITION	116	1.2	471	1959
131	PROPERTIES	121	1.3	471	4108
132	REDUCTION	52	0.6	465	1295
133	STEROL	94	1.0	459	2650
134	ACTION	96	1.0	457	2572
135	SUPPLEMENTATION	79	0.8	454	1513
136	MAN	73	0.8	449	3163
137	MECHANISM	64	0.7	447	3255
138	STRUCTURE	66	0.7	447	2889
139	CHOLESTEROL-FED	106	1.1	445	2109
140	FORMATION	104	1.1	436	1847
141	CHRONIC	54	0.6	435	997
142	TREATMENT	115	1.2	430	2568
143	CORONARY	115	1.2	428	5809
144	DISTRIBUTION	88	0.9	423	1580
145	LOW	67	0.7	420	1367
146	FATS	116	1.2	419	1863
147	MECHANISMS	75	0.8	412	2827
148	FREE	62	0.7	410	1379
149	PLASMA-LIPIDS	57	0.6	410	1248
150	INDUCED	141	1.5	409	2080
#	Word	Pubs	Percent	TLCS	TGCS
151	EVIDENCE	57	0.6	408	2790
152	BUTTER	28	0.3	404	551
153	DIMETHYLBENZ	30	0.3	404	682
154	PIGS	78	0.8	404	1106
155	CYSTIC-FIBROSIS	64	0.7	403	2508
156	CONCENTRATION	70	0.7	402	1241
157	COLONIC	73	0.8	399	1658
158	CARBOHYDRATES	51	0.5	398	1186
159	IN-VITRO	38	0.4	393	2843
160	EARLY	48	0.5	392	1000
161	ALFALFA	18	0.2	391	609
162	AMINO-ACID	16	0.2	391	643
163	CHOLESTERYL	91	1.0	389	1878
164	METABOLIC	98	1.0	386	2890
165	OILS	77	0.8	378	1046
166	ANTHRACENE-INDUCED	20	0.2	374	492
167	CULTURE	87	0.9	374	2670
168	REGULATION	84	0.9	374	4180
169	FACTORS	99	1.0	371	2712
170	PROLIFERATION	60	0.6	370	1769
171	POTENTIAL	75	0.8	369	2254
172	RELATIONSHIP	72	0.8	364	1971
173	COMPONENTS	56	0.6	363	1538
174	HEART	74	0.8	359	3956
175	NEUTRAL	60	0.6	356	1788
176	TOTAL	94	1.0	350	1415
177	INTERACTION	59	0.6	349	1250
178	FIBROBLASTS	110	1.2	340	2682
179	BLOOD	146	1.5	339	2938
180	ACCUMULATION	61	0.6	338	1680
#	Word	Pubs	Percent	TLCS	TGCS
181	NONNUTRITIVE	3	0.0	336	336
182	AORTA	81	0.9	334	1940
183	AZOXYMETHANE-INDUCED	18	0.2	333	759
184	CONSUMPTION	68	0.7	332	1622
185	SOURCE	37	0.4	331	645
186	RESPONSE	82	0.9	330	1805
187	SEMIPURIFIED	24	0.3	328	580
188	LEVEL	72	0.8	326	1317
189	SATURATED	67	0.7	326	1504
190	TRANSPORT	68	0.7	326	2147
191	CELLULOSE	52	0.6	325	805
192	MALE	73	0.8	320	1318
193	ARGININE	22	0.2	315	532
194	LYMPHATIC	32	0.3	315	901
195	OAT	42	0.4	315	1014
196	FOOD	120	1.3	312	1718
197	WOMEN	81	0.9	312	3365
198	PROTEIN-DIET	10	0.1	308	422
199	MIXTURES	18	0.2	304	625
200	PHOSPHOLIPIDS	49	0.5	304	969
201	ESSENTIAL	46	0.5	302	1605
202	HYPERCHOLESTEREMIA	19	0.2	301	622
203	NUTRITION	120	1.3	301	2156
204	RATIO	27	0.3	301	555
205	GUM	47	0.5	295	842
206	LOW-DENSITY	70	0.7	293	3808
207	TYPES	26	0.3	293	582
208	PREVENTION	110	1.2	292	2794
209	PLANT	59	0.6	291	1312
210	INCREASED	58	0.6	290	1434
#	Word	Pubs	Percent	TLCS	TGCS
211	THIN-LAYER	63	0.7	288	1459
212	SOURCES	44	0.5	284	814
213	EXPRESSION	60	0.6	278	1091
214	CALORIES	22	0.2	277	657
215	TYPE	64	0.7	275	799
216	CULTURED	104	1.1	272	2689
217	HEALTH	93	1.0	272	2491
218	YOUNG	70	0.7	272	1345
219	HIGH-FAT	49	0.5	270	792
220	ESTERASE	33	0.3	269	698
221	INITIATION	16	0.2	268	478
222	OBSERVATIONS	22	0.2	267	2454
223	ANALYSIS	99	1.0	266	2433
224	CELLULAR	47	0.5	266	2385
225	NUTRITIONAL	103	1.1	266	2042
226	CHOLESTYRAMINE	38	0.4	265	711
227	MITOCHONDRIA	41	0.4	265	752
228	SAPONINS	26	0.3	265	909
229	AGENTS	58	0.6	264	1232
230	LYSINE	18	0.2	264	364
231	GUAR	40	0.4	263	742
232	MOUSE	77	0.8	263	1678
233	CELL-PROLIFERATION	21	0.2	259	949
234	STEROID-EXCRETION	14	0.1	259	434
235	CHOLESTEROL-LOWERING	50	0.5	258	1030
236	ATHEROGENIC	56	0.6	257	1042
237	TISSUES	71	0.8	257	1168
238	REDUCE	36	0.4	256	739
239	MEAT	29	0.3	255	1254
240	PRODUCTION	88	0.9	253	1172
#	Word	Pubs	Percent	TLCS	TGCS
241	CHEMICALLY-INDUCED	7	0.1	250	369
242	ATHEROGENESIS	57	0.6	245	1723
243	HYPOLIPIDEMIC	83	0.9	244	1952
244	ENZYME	40	0.4	243	718
245	BREAST	63	0.7	242	1696
246	STRAIN	22	0.2	242	534
247	MODULATION	46	0.5	240	1522
248	INSULIN	45	0.5	238	1180
249	MIXED	16	0.2	236	338
250	PSYLLIUM	30	0.3	236	711
251	LESIONS	55	0.6	234	1852
252	GROWTH-FACTOR	8	0.1	232	378
253	INDUCTION	43	0.5	232	1547
254	PHASE	27	0.3	232	639
255	RANDOMIZED	26	0.3	231	718
256	DETERMINATION	72	0.8	230	2177
257	BRAIN	64	0.7	229	1181
258	PALM	49	0.5	229	400
259	ASPECTS	53	0.6	228	1757
260	FEMALE	62	0.7	228	544
261	VITRO	75	0.8	228	1217
262	COCOA	19	0.2	227	300
263	GARLIC	39	0.4	225	1030
264	MODEL	75	0.8	225	2127
265	QUANTITATIVE	45	0.5	225	1881
266	AGE-RELATED-CHANGES	26	0.3	224	616
267	CHICKENS	27	0.3	224	374
268	AMINO-ACIDS	33	0.3	222	488
269	SECRETION	50	0.5	220	1218
270	THYROID	32	0.3	220	1046
#	Word	Pubs	Percent	TLCS	TGCS
271	COMPARATIVE	56	0.6	219	1599
272	INDUCES	18	0.2	219	788
273	SEPARATION	45	0.5	219	1265
274	LIQUID	33	0.3	218	976
275	DAIRY	26	0.3	217	568
276	METHOD	47	0.5	217	1050
277	INFLUENCES	22	0.2	216	1063
278	DIMETHYLHYDRAZINE	17	0.2	214	568
279	FRACTIONS	48	0.5	213	1006
280	ISOMER	18	0.2	213	392
281	MIXTURE	22	0.2	213	351
282	POSSIBLE	49	0.5	213	1592
283	MODULATES	13	0.1	212	339
284	COCONUT	32	0.3	211	350
285	COLORECTAL	53	0.6	211	1618
286	SWINE	35	0.4	208	510
287	ASSAY	30	0.3	206	717
288	FUNCTION	74	0.8	205	2050
289	STEARIC-ACID	12	0.1	204	708
290	ACTIVITIES	48	0.5	203	751
291	PLASMA-LIPOPROTEINS	32	0.3	203	945
292	ATHEROSCLEROTIC	80	0.8	200	2386
293	ULTRASTRUCTURAL	14	0.1	200	491
294	ARTERIAL	62	0.7	199	2462
295	COMPOUNDS	48	0.5	199	996
296	CORN	32	0.3	199	312
297	INHIBITS	28	0.3	199	1204
298	CATABOLISM	25	0.3	198	818
299	PRIMARY	42	0.4	198	1496
300	RELATED	40	0.4	198	1072
#	Word	Pubs	Percent	TLCS	TGCS
301	CORN-OIL	26	0.3	197	411
302	HAMSTER	44	0.5	196	1011
303	MICELLES	9	0.1	196	310
304	METABOLITES	21	0.2	195	621
305	BEEF	39	0.4	194	476
306	TREATED	41	0.4	194	945
307	TRIGLYCERIDES	67	0.7	193	1705
308	ALTER	19	0.2	192	513
309	SEMI-PURIFIED	8	0.1	192	258
310	PRODUCTS	66	0.7	191	981
311	T3-L	9	0.1	187	315
312	TUMOR	72	0.8	187	1078
313	AGE	45	0.5	186	1606
314	LDL	43	0.5	186	1069
315	REGRESSION	30	0.3	186	644
316	ESTERIFIED	24	0.3	185	670
317	MEDIUM-CHAIN	33	0.3	185	1360
318	SMALL-INTESTINE	19	0.2	185	498
319	BIOCHEMICAL	58	0.6	184	1914
320	EPIDEMIOLOGIC	17	0.2	184	956
321	UPTAKE	59	0.6	184	1215
322	DEGRADATION	37	0.4	183	803
323	HEART-DISEASE	46	0.5	182	1802
324	JEJUNUM	10	0.1	181	372
325	METHYLNITROSOUREA-INDUCED	5	0.1	181	205
326	FISCHER	23	0.2	180	778
327	HORMONES	34	0.4	180	1115
328	SUBJECTS	60	0.6	180	1178
329	SCANNING	15	0.2	179	230
330	ELECTRON-MICROSCOPY	14	0.1	178	254
#	Word	Pubs	Percent	TLCS	TGCS
331	NEW	102	1.1	178	1390
332	EVALUATION	68	0.7	177	1976
333	ISOLATED	58	0.6	177	1216
334	ADMINISTRATION	52	0.6	176	1034
335	APOPTOSIS	31	0.3	176	954
336	CALORIE	22	0.2	176	489
337	CIRCULATING	24	0.3	175	546
338	BREAST-CANCER	40	0.4	174	1341
339	PROBUCOL	39	0.4	174	2301
340	ADIPOSE	26	0.3	173	571
341	ENHANCED	19	0.2	173	393
342	PHYSIOLOGICAL	42	0.4	172	1113
343	SMOOTH-MUSCLE	35	0.4	172	1348
344	POLYUNSATURATED	46	0.5	171	1245
345	SPECIES	48	0.5	171	811
346	CLINICAL-EXPERIENCE	2	0.0	170	199
347	SIZE	28	0.3	169	535
348	STATUS	50	0.5	169	997
349	INCREASES	37	0.4	168	785
350	LEAN	14	0.1	167	331
351	MAMMARY-TUMORS	13	0.1	167	322
352	MODIFICATION	37	0.4	167	1165
353	VERVET	28	0.3	167	222
354	HIGH-PERFORMANCE	22	0.2	166	557
355	CARDIOVASCULAR	59	0.6	165	1190
356	COLON-TUMOR	3	0.0	165	187
357	ENHANCEMENT	22	0.2	165	585
358	IMPROVED	24	0.3	165	1047
359	MASS	29	0.3	165	1747
360	DRUGS	70	0.7	164	2083
#	Word	Pubs	Percent	TLCS	TGCS
361	MAMMARY-TUMOR	19	0.2	164	464
362	RECEPTOR	33	0.3	164	859
363	VIVO	33	0.3	163	964
364	GROWING	35	0.4	162	464
365	PEROXISOME	17	0.2	162	1494
366	REDUCTASE	43	0.5	162	1019
367	SOYA	17	0.2	162	349
368	MOLECULAR	43	0.5	160	2507
369	MUCOSAL	22	0.2	160	691
370	RADIOACTIVE	11	0.1	160	258
371	FACTOR	45	0.5	159	1504
372	FOODS	57	0.6	159	1602
373	TUMORS	41	0.4	159	660
374	CONVERSION	27	0.3	158	1178
375	INCIDENCE	27	0.3	158	670
376	DISTRIBUTIONS	12	0.1	157	417
377	ISOLATE	25	0.3	157	341
378	LONG-TERM	55	0.6	157	1005
379	BILIARY	43	0.5	156	786
380	TISSUE-CULTURE	9	0.1	155	329
381	COWS	25	0.3	154	587
382	DECREASES	23	0.2	154	470
383	DESATURASE	10	0.1	154	303
384	RECOVERY	14	0.1	154	249
385	REPORT	23	0.2	154	945
386	STATEMENT	9	0.1	154	646
387	BABOONS	20	0.2	153	342
388	DIFFERENCES	36	0.4	153	741
389	ALTERATIONS	45	0.5	152	638
390	LUNG	25	0.3	152	800
#	Word	Pubs	Percent	TLCS	TGCS
391	AFFECTING	33	0.3	151	977
392	INTESTINAL-ABSORPTION	17	0.2	151	563
393	PROFILES	40	0.4	151	1283
394	BOVINE	46	0.5	150	839
395	DEPOSITION	20	0.2	150	466
396	DMBA-INDUCED	13	0.1	150	201
397	DIGESTION	30	0.3	149	959
398	LYSOLECITHIN	20	0.2	149	720
399	NICOTINIC	22	0.2	149	493
400	OBESE	30	0.3	148	570
401	SPRAGUE-DAWLEY	35	0.4	148	420
402	STARCH	57	0.6	148	820
403	PROGRESSION	23	0.2	147	1427
404	USE	62	0.7	147	1958
405	BOWEL	17	0.2	146	646
406	EXERCISE	29	0.3	146	541
407	OXIDATIVE	43	0.5	146	1777
408	RAT-LIVER	48	0.5	146	1244
409	STEAROYL-COA	7	0.1	146	323
410	DESMOSTEROL	18	0.2	145	313
411	ISOMERIC	17	0.2	145	467
412	HYPERLIPIDEMIC	30	0.3	144	1476
413	TOPOGRAPHY	3	0.0	144	149
414	VEGETABLES	18	0.2	144	1253
415	ADSORPTION	21	0.2	142	275
416	ALTERS	23	0.2	142	489
417	COLORECTAL-CANCER	29	0.3	142	835
418	FAMILIAL	25	0.3	142	1526
419	LOW-FAT	23	0.2	142	778
420	EPIDEMIOLOGY	26	0.3	141	899
#	Word	Pubs	Percent	TLCS	TGCS
421	SCID	3	0.0	141	141
422	PROTECTIVE	27	0.3	140	807
423	ASSOCIATED	46	0.5	139	1141
424	CALCIUM	60	0.6	139	1192
425	HIGH-FIBER	20	0.2	139	694
426	PURIFIED	23	0.2	139	372
427	HIGH-DENSITY	31	0.3	138	1478
428	IDENTIFICATION	36	0.4	138	833
429	MONKEY	25	0.3	138	536
430	ATHEROGENICITY	9	0.1	137	137
431	CLOFIBRATE	55	0.6	137	1134
432	FISH	55	0.6	137	1014
433	POPULATION	28	0.3	137	669
434	OCCURRENCE	18	0.2	136	371
435	RHESUS-MONKEYS	23	0.2	135	880
436	APOLIPOPROTEINS	13	0.1	134	589
437	DECREASE	12	0.1	134	296
438	INSULIN-LIKE	20	0.2	134	1341
439	PANCREATIC	34	0.4	134	531
440	RED	55	0.6	134	942
441	CEREAL	25	0.3	133	579
442	CHOLESTEREMIA	10	0.1	133	349
443	GALLSTONE	28	0.3	133	417
444	STIMULATION	31	0.3	132	977
445	TRIAL	27	0.3	132	1038
446	CHROMATOGRAPHIC	31	0.3	131	520
447	ENZYMATIC	27	0.3	131	513
448	ASSESSMENT	33	0.3	130	1098
449	PREADIPOCYTES	6	0.1	130	209
450	QUANTITATION	17	0.2	130	427
#	Word	Pubs	Percent	TLCS	TGCS
451	RESPONSES	52	0.6	130	500
452	STEROID	41	0.4	130	1193
453	AFFECT	23	0.2	129	406
454	CHARACTERISTICS	41	0.4	129	702
455	LINE	10	0.1	129	330
456	ORIGIN	30	0.3	129	904
457	VITAMIN-E	36	0.4	129	821
458	BLOOD-LIPIDS	19	0.2	128	433
459	DISEASES	26	0.3	128	2460
460	SERUM-LIPOPROTEINS	20	0.2	128	454
461	FIBERS	35	0.4	127	472
462	HEALTHY	48	0.5	127	919
463	SUPPRESSES	16	0.2	127	214
464	WHOLE	19	0.2	127	351
465	ESTERS	53	0.6	126	1388
466	ROUGHAGE	5	0.1	126	182
467	SEQUESTRANTS	3	0.0	126	137
468	SPECIFIC	40	0.4	126	671
469	CHARACTERIZATION	65	0.7	125	1483
470	CONTROL	50	0.5	125	1035
471	FEED-EFFICIENCY	3	0.0	125	155
472	LYSOSOMAL	29	0.3	125	794
473	INCORPORATION	54	0.6	124	855
474	BODY-WEIGHT	8	0.1	123	374
475	BONE	16	0.2	123	320
476	CANCERS	18	0.2	123	950
477	FLUX	6	0.1	123	479
478	SIMPLE	25	0.3	123	483
479	DIGESTIBILITY	37	0.4	121	525
480	USING	50	0.5	121	1102
#	Word	Pubs	Percent	TLCS	TGCS
481	DEUTERIUM	33	0.3	120	390
482	HYDROLYSATES	3	0.0	120	173
483	INCREASE	32	0.3	120	530
484	SEMISYNTHETIC	5	0.1	119	157
485	SQUALENE	43	0.5	119	627
486	ESTERIFICATION	42	0.4	118	669
487	HYBRID	6	0.1	118	144
488	CHICKEN	30	0.3	117	411
489	DEVELOPING	32	0.3	117	733
490	TRIACYLGLYCEROL	42	0.4	117	655
491	HYDROGEN	4	0.0	116	193
492	IMPLICATIONS	53	0.6	116	1903
493	SKIM	22	0.2	116	253
494	ADENOCARCINOMA	12	0.1	115	260
495	GENE	35	0.4	115	856
496	ACYLTRANSFERASE	30	0.3	114	1326
497	DIMETHYLHYDRAZINE-INDUCED	17	0.2	114	267
498	GLAND	16	0.2	114	439
499	TIME	21	0.2	114	693
500	UNSATURATED	31	0.3	114	618
501	GLYCOLYSIS	8	0.1	113	220
502	PHOSPHOLIPID	37	0.4	112	1547
503	ARTERY	21	0.2	111	704
504	KINETICS	24	0.3	111	465
505	VARIATIONS	17	0.2	111	366
506	HYPERLIPEMIC	19	0.2	110	577
507	METHIONINE	18	0.2	110	419
508	PRODUCT	18	0.2	110	360
509	RESEARCH	39	0.4	110	777
510	AFFECTS	24	0.3	109	368
#	Word	Pubs	Percent	TLCS	TGCS
511	ENZYMES	57	0.6	109	1291
512	INTESTINE	22	0.2	109	437
513	LARD	12	0.1	109	247
514	WEIGHT-GAIN	3	0.0	109	141
515	PROPORTIONS	4	0.0	108	170
516	SIGNIFICANCE	25	0.3	108	932
517	SMALL	28	0.3	108	433
518	ANTICARCINOGENIC	13	0.1	107	398
519	EICOSANOID	13	0.1	107	677
520	FEED	7	0.1	107	190
521	HYDROXY-3-METHYLGLUTARYL	25	0.3	107	701
522	INFLUENCED	13	0.1	107	243
523	LECITHIN	26	0.3	107	690
524	CHOW	2	0.0	106	109
525	COMMERCIAL	14	0.1	106	216
526	GAS	18	0.2	106	472
527	HETEROKARYOCYTE	1	0.0	106	106
528	HOMOKARYOCYTE	1	0.0	106	106
529	HYPERLIPOPROTEINEMIA	31	0.3	106	739
530	RADIOASSAY	5	0.1	106	172
531	LARGE	22	0.2	105	536
532	POSTPRANDIAL	32	0.3	105	451
533	PROSPECTIVE-STUDY	6	0.1	105	1044
534	TRANSFER	29	0.3	105	1916
535	HYDROLASE	34	0.4	104	391
536	LOWERS	17	0.2	104	238
537	MEDIUM	34	0.4	104	529
538	ACTIVE	19	0.2	103	437
539	CASE-CONTROL	11	0.1	103	780
540	CARRAGEENAN	4	0.0	102	178
#	Word	Pubs	Percent	TLCS	TGCS
541	CHITOSAN	20	0.2	102	471
542	MCT	5	0.1	102	116
543	ANTI-HYPERCHOLESTEROLEMIC	2	0.0	101	208
544	CHEMICAL	42	0.4	101	648
545	CHICK	31	0.3	101	574
546	ENDOTHELIAL	39	0.4	101	1156
547	ENERGY-INTAKE	7	0.1	101	204
548	KERNEL	11	0.1	101	130
549	MORPHOLOGICAL	21	0.2	101	349
550	VARYING	18	0.2	101	376
551	FATE	8	0.1	100	264
552	IMMUNE	23	0.2	100	642
553	PRIMATES	23	0.2	100	658
554	RECTUM	9	0.1	100	699
555	SUPPRESSION	30	0.3	100	771
556	WHITE	32	0.3	100	375
557	ATHEROMATOUS	12	0.1	99	608
558	C57BL	15	0.2	99	330
559	GLYCINE	14	0.1	99	190
560	INTERACTIONS	35	0.4	99	1149
561	ISCHEMIC-HEART	1	0.0	99	327
562	NET	4	0.0	99	185
563	PARAMETERS	40	0.4	99	425
564	VITAMIN-C	18	0.2	99	707
565	EGG	33	0.3	98	399
566	MEASUREMENT	35	0.4	98	1291
567	MORPHOLOGY	24	0.3	98	403
568	SKIN	48	0.5	98	729
569	ASSOCIATION	34	0.4	97	940
570	COLON-CANCER	14	0.1	97	693
#	Word	Pubs	Percent	TLCS	TGCS
571	OLIVE	25	0.3	97	344
572	ABNORMAL	10	0.1	96	305
573	COUNTERPARTS	3	0.0	96	173
574	GLYCEROL	16	0.2	96	247
575	INVIVO	39	0.4	96	896
576	PROSTAGLANDIN	7	0.1	96	164
577	ISOCALORIC	4	0.0	95	104
578	ISOGRAVIC	2	0.0	95	95
579	SILVER-ION	5	0.1	95	184
580	ALPHA-HYDROXYLASE	18	0.2	94	878
581	DEGREE	7	0.1	94	117
582	FACTOR-I	6	0.1	94	267
583	IMPACT	30	0.3	94	549
584	LEPTIN	9	0.1	94	188
585	LUMINAL	9	0.1	94	414
586	PROTEIN-TYPE	1	0.0	94	161
587	SENESCENT	15	0.2	94	408
588	TEXTURED	3	0.0	94	153
589	CULTURES	30	0.3	93	863
590	DEVOID	2	0.0	93	143
591	ION	8	0.1	93	253
592	LIPID-COMPOSITION	28	0.3	93	518
593	LOW-DENSITY-LIPOPROTEIN	18	0.2	93	857
594	METAANALYSIS	2	0.0	93	721
595	PATHOGENESIS	28	0.3	93	2746
596	RATIONS	5	0.1	93	152
597	REFERENCE	18	0.2	93	540
598	RICE	33	0.3	93	231
599	CRITICAL-REVIEW	2	0.0	92	350
600	DERIVATIVES	37	0.4	92	923

Page 1:  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19